Tina L. Cheng

Tina Lee Cheng is an American pediatrician. In 2020, she was named the Chair of Pediatrics, Chief Medical Officer, and Research Foundation Director of Cincinnati Children's Hospital Medical Center and was previously Director of Pediatrics and Pediatrician-In-Chief at Johns Hopkins University. Provided by Wikipedia
Showing 1 - 18 results of 18 for search 'Tina Cheng', query time: 0.07s Refine Results
  1. 1
    Synergistic Anti-<em>Candida</em> Activity of Bengazole A in the Presence of Bengamide A

    Synergistic Anti-<em>Candida</em> Activity of Bengazole A in the Presence of Bengamide A by Matthew T. Jamison, Xiao Wang, Tina Cheng, Tadeusz F. Molinski

    Published 2019-02-01
    Get full text
    Article
  2. 2
    The Role of Tailored Public Health Messaging to Young Adults during COVID-19: "There's a lot of ambiguity around what it means to be safe".

    The Role of Tailored Public Health Messaging to Young Adults during COVID-19: "There's a lot of ambiguity around what it means to be safe". by Tina Cheng, Braxtyn Horbay, Rochelle Nocos, Lesley Lutes, Scott A Lear

    Published 2021-01-01
    Get full text
    Article
  3. 3
    Not Waiting to Progress; How the COVID-19 Pandemic Nudged Neoadjuvant Therapy for Stage III Locally Advanced Melanoma Patients

    Not Waiting to Progress; How the COVID-19 Pandemic Nudged Neoadjuvant Therapy for Stage III Locally Advanced Melanoma Patients by Katie Kinaschuk, Tina Cheng, Thomas Brenn, J. Gregory McKinnon, Claire Temple-Oberle

    Published 2023-04-01
    Get full text
    Article
  4. 4
    2450

    2450 by Antony Gatebe Kironji, Tina Cheng, Vanya Jones, Sarah Lindstrom Johnson, Joel Fein, Leticia Ryan

    Published 2017-09-01
    Get full text
    Article
  5. 5
    Comparing the associations between host and tumor factors with survival outcomes with anti‐PD‐1 immunotherapy in metastatic melanoma

    Comparing the associations between host and tumor factors with survival outcomes with anti‐PD‐1 immunotherapy in metastatic melanoma by Kim Koczka, Rodrigo Rigo, Eugene Batuyong, Sara Cook, Mohammad Asad, Isabelle Vallerand, Aleksi Suo, Edwin Wang, Tina Cheng

    Published 2023-02-01
    Get full text
    Article
  6. 6
    Real World Outcomes in Patients with Advanced Melanoma Treated in Alberta, Canada: A Time-Era Based Analysis

    Real World Outcomes in Patients with Advanced Melanoma Treated in Alberta, Canada: A Time-Era Based Analysis by Rodrigo Rigo, Jordan Doherty, Kim Koczka, Shiying Kong, Philip Q. Ding, Tina Cheng, Winson Y. Cheung, Jose G. Monzon

    Published 2021-10-01
    Get full text
    Article
  7. 7
    A Web-Based Risk-Reframing Intervention to Influence Early Childhood Educators’ Attitudes and Supportive Behaviors Toward Outdoor Play: Protocol for the OutsidePlay Study Randomized Controlled Trial

    A Web-Based Risk-Reframing Intervention to Influence Early Childhood Educators’ Attitudes and Supportive Behaviors Toward Outdoor Play: Protocol for the OutsidePlay Study Randomize... by Mariana Brussoni, Christina S Han, John Jacob, Fritha Munday, Megan Zeni, Melanie Walters, Tina Cheng, Amy Schneeberg, Emily Fox, Eva Oberle

    Published 2021-11-01
    Get full text
    Article
  8. 8
    Clinical Factors Associated with Long-Term Survival in Metastatic Melanoma Treated with Anti-PD1 Alone or in Combination with Ipilimumab

    Clinical Factors Associated with Long-Term Survival in Metastatic Melanoma Treated with Anti-PD1 Alone or in Combination with Ipilimumab by Siddhartha Goutam, Igor Stukalin, Benjamin Ewanchuk, Michael Sander, Philip Q. Ding, Daniel E. Meyers, Daniel Heng, Winson Y. Cheung, Tina Cheng

    Published 2022-10-01
    Get full text
    Article
  9. 9
    Effectiveness of Immune Checkpoint Inhibitor with Anti-PD-1 Monotherapy or in Combination with Ipilimumab in Younger versus Older Adults with Advanced Melanoma

    Effectiveness of Immune Checkpoint Inhibitor with Anti-PD-1 Monotherapy or in Combination with Ipilimumab in Younger versus Older Adults with Advanced Melanoma by Taylor E. Woo, Igor Stukalin, Philip Q. Ding, Siddhartha Goutam, Michael Sander, Benjamin Ewanchuk, Winson Y. Cheung, Daniel Y. C. Heng, Tina Cheng

    Published 2023-09-01
    Get full text
    Article
  10. 10
    Evaluation of the modified immune prognostic index to prognosticate outcomes in metastatic uveal melanoma patients treated with immune checkpoint inhibitors

    Evaluation of the modified immune prognostic index to prognosticate outcomes in metastatic uveal melanoma patients treated with immune checkpoint inhibitors by Michael S. Sander, Igor Stukalin, Isabelle A. Vallerand, Siddhartha Goutam, Benjamin W. Ewanchuk, Daniel E. Meyers, Aliyah Pabani, Don G. Morris, Daniel Y. C. Heng, Tina Cheng

    Published 2021-04-01
    Get full text
    Article
  11. 11
    Rediscovery of the critically endangered Hill's horseshoe bat (Rhinolophus hilli) and other new records of bat species in Rwanda

    Rediscovery of the critically endangered Hill's horseshoe bat (Rhinolophus hilli) and other new records of bat species in Rwanda by Jon Flanders, Winifred Frick, Julius Nziza, Olivier Nsengimana, Prince Kaleme, Marie Claire Dusabe, Innocent Ndikubwimana, Innocent Twizeyimana, Sospeter Kibiwot, Pierre Ntihemuka, Tina Cheng, Richard Muvunyi, Paul Webala

    Published 2022-05-01
    Get full text
    Article
  12. 12
    Pathogen invasion history elucidates contemporary host pathogen dynamics.

    Pathogen invasion history elucidates contemporary host pathogen dynamics. by Vance T Vredenburg, Samuel V G McNally, Hasan Sulaeman, Helen M Butler, Tiffany Yap, Michelle S Koo, Dirk S Schmeller, Celeste Dodge, Tina Cheng, Gordon Lau, Cheryl J Briggs

    Published 2019-01-01
    Get full text
    Article
  13. 13
    The Lung Immune Prognostic Index Discriminates Survival Outcomes in Patients with Solid Tumors Treated with Immune Checkpoint Inhibitors

    The Lung Immune Prognostic Index Discriminates Survival Outcomes in Patients with Solid Tumors Treated with Immune Checkpoint Inhibitors by Daniel E. Meyers, Igor Stukalin, Isabelle A. Vallerand, Ryan T. Lewinson, Aleksi Suo, Michelle Dean, Scott North, Aliyah Pabani, Tina Cheng, Daniel Y.C. Heng, D. Gwyn Bebb, Don G. Morris

    Published 2019-11-01
    Get full text
    Article
  14. 14
    Environment is associated with chytrid infection and skin microbiome richness on an amphibian rich island (Taiwan)

    Environment is associated with chytrid infection and skin microbiome richness on an amphibian rich island (Taiwan) by Dirk S. Schmeller, Tina Cheng, Jennifer Shelton, Chun-Fu Lin, Alan Chan-Alvarado, Adriana Bernardo-Cravo, Luca Zoccarato, Tzung-Su Ding, Yu-Pin Lin, Andrea Swei, Matthew C. Fisher, Vance T. Vredenburg, Adeline Loyau

    Published 2022-09-01
    Get full text
    Article
  15. 15
    Management of Uveal Melanoma: Updated Cancer Care Alberta Clinical Practice Guideline

    Management of Uveal Melanoma: Updated Cancer Care Alberta Clinical Practice Guideline by Ezekiel Weis, Brae Surgeoner, Thomas G. Salopek, Tina Cheng, Martin Hyrcza, Xanthoula Kostaras, Matthew Larocque, Greg McKinnon, John McWhae, Geetha Menon, Jose Monzon, Albert D. Murtha, John Walker, Claire Temple-Oberle

    Published 2023-12-01
    Get full text
    Article
  16. 16
    CANDIED: A Pan-Canadian Cohort of Immune Checkpoint Inhibitor-Induced Insulin-Dependent Diabetes Mellitus

    CANDIED: A Pan-Canadian Cohort of Immune Checkpoint Inhibitor-Induced Insulin-Dependent Diabetes Mellitus by Thiago P. Muniz, Daniel V. Araujo, Kerry J. Savage, Tina Cheng, Moumita Saha, Xinni Song, Sabrina Gill, Jose G. Monzon, Debjani Grenier, Sofia Genta, Michael J. Allen, Diana P. Arteaga, Samuel D. Saibil, Marcus O. Butler, Anna Spreafico, David Hogg

    Published 2021-12-01
    Get full text
    Article
  17. 17
    Biomarker and pharmacodynamic activity of the transforming growth factor‐beta (TGFβ) inhibitor SAR439459 as monotherapy and in combination with cemiplimab in a phase I clinical study in patients with advanced solid tumors

    Biomarker and pharmacodynamic activity of the transforming growth factor‐beta (TGFβ) inhibitor SAR439459 as monotherapy and in combination with cemiplimab in a phase I clinical stu... by Debbie Robbrecht, Jean‐Jacques Grob, Oliver Bechter, Matteo Simonelli, Bernard Doger, Ivan Borbath, Marcus O. Butler, Tina Cheng, Patricia Martin Romano, Elvire Pons‐Tostivint, Massimo Di Nicola, Giuseppe Curigliano, Min‐Hee Ryu, Alejo Rodriguez‐Vida, Dirk Schadendorf, Elena Garralda, Giovanni Abbadessa, Brigitte Demers, Amele Amrate, Hong Wang, Joon Sang Lee, Robert Pomponio, Rui Wang

    Published 2024-02-01
    Get full text
    Article
  18. 18
    Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first‐line chemotherapy for metastatic germ cell tumors: A study by the global germ cell cancer group (G3)

    Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first‐line chemotherapy for metastatic germ cell tumors: A study by the glo... by Ben Tran, Jose M. Ruiz‐Morales, Enrique Gonzalez‐Billalabeitia, Anna Patrikidou, Eitan Amir, Christoph Seidel, Carsten Bokemeyer, Christian Fankhauser, Thomas Hermanns, Alexey Rumyantsev, Alexey Tryakin, Margarida Brito, Aude Fléchon, Edmond Michael Kwan, Tina Cheng, Daniel Castellano, Xavier Garcia del Muro, Anis A. Hamid, Margaret Ottaviano, Giovannella Palmieri, Robert Kitson, Alison Reid, Daniel Y. C. Heng, Philippe L. Bedard

    Published 2020-01-01
    Get full text
    Article

Search Tools: